CYP2D6 is a key enzyme for metabolizing many drugs, including some antidepressants, beta-blockers, and opioids. Genetic variants can alter enzyme activity (poor, intermediate, extensive, ultrarapid metabolizer). For weight loss itself, there is no strong direct evidence that CYP2D6 variants predict success without medication. However, they can affect the efficacy and side effects of drugs sometimes used for weight management (e.g., bupropion). Some studies suggest links to neurotransmitter metabolism, but clinical relevance for diet or exercise is low. MyBody-X may test CYP2D6 as part of drug response analysis, not specifically for weight loss. Caution: Do not self-medicate; consult a doctor if taking medications. Evidence: human-moderate for drug metabolism, but for weight loss it is mechanistic/unclear.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-76dd1725078a28b85e2d0959